Early predictors of 30-day mortality in supratentorial ischemic stroke patients--firstepisode.
A Szczudiik, A Słowik, W Turaj, G Zwolińska, U Wyrwicz-Petkow, K Kasprzyk, M BosakMed Sci Monit 2000; 6(1): CR75-80 :: ID: 432826
Abstract
INTRODUCTION: Prognostic factors following stroke remain to be established.The aim of this study was to determine early prognostic factors related with a 30-day mortality in firstepisode ischemic stroke patients. MATERIALS AND METHODS: The study group comprised 329 consecutive patients,aged between 33 and 99 years (mean age +/- SD 69 +/- 12.6) admitted within 24 hours following their firstsupratentorial ischemic stroke, confirmed either by computer tomography (CT) and/or autopsy. The followingdata were assessed within 24 hours of hospitalization: gender, age, history of diabetes mellitus, historyof ischemic heart disease, obesity, the neurological deficit at entry and after one day, level of consciousnessat entry and after one day, electrocardiographic dysrhythmia at entry, blood pressure at entry and bodytemperature on the first day following stroke. We also assessed particular serum biochemical and hematologicalmarkers including: hematocrit, fibrinogen concentration, platelet count, white blood cell (WBC) count,gamma globulin level, glucose level, cholesterol level, the erythrocyte sedimentation rate (ESR), andcreatinine kinase (CK) level. The end-point for assessment was early death (within 30 days). Statisticalanalysis consisted of univariate analysis and multiple regression. RESULTS: Univariate analysis demonstratedthat an older age, increased neurological deficit at entry and on the next day, decreased consciousnessat entry and on the next day, electrocardiographic dysrhythmia, increased body temperature and glucoselevel, decreased cholesterol level and increased CK level were significantly associated with death after30 days (p < or = 0.05). During multivariate analysis, only a severe neurological deficit (ScandinavianStroke Scale < or = 15 points) both at entry and on the next day (OR = 8.3; 95% CI: 2.83-24.35), decreasedconsciousness within the first 24 hours of hospitalization (OR = 19.2; 95% CI: 2.84-127.77) and electrocardiographicdysrhythmia (OR = 5.2; 95% CI: 2.37-13.77) were associated with death after 30 days. CONCLUSION: A severeneurological deficit lasting 24 hours, decreased consciousness within 24 hours of hospitalization andelectrocardiographic dysrhythmia are the most important indicators of 30-day mortality in patients withfirst-time ischemic stroke.
Keywords: Time Factors
Editorial
01 January 2025 : Editorial
Editorial: The Human Cell Atlas. What Is It and Where Could It Take Us?DOI: 10.12659/MSM.947707
Med Sci Monit 2025; 31:e947707
In Press
Clinical Research
Impact of Smovey Vibration Versus Dumbbell Resistance on Muscle Activation in WomenMed Sci Monit In Press; DOI: 10.12659/MSM.946567
Clinical Research
Five-Year Impact of Weight Loss on Knee Pain and Quality of Life in Obese PatientsMed Sci Monit In Press; DOI: 10.12659/MSM.946550
Clinical Research
Butorphanol Tartrate Nasal Spray for Post-Cesarean Analgesia and Prolactin SecretionMed Sci Monit In Press; DOI: 10.12659/MSM.945224
Database Analysis
Role of the Carhart Effect and Outcomes from Surgery: A Retrospective Study of 532 Patients with Conductive...Med Sci Monit In Press; DOI: 10.12659/MSM.947061
Most Viewed Current Articles
17 Jan 2024 : Review article 6,963,045
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 700,086
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 23,449
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 18,141
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912